← Eichor
Study identifier: NCT03023371 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

National Registry of IgG4-RD in China

Condition: IgG4-Related Disease  ·  Sponsor: Peking Union Medical College Hospital

PhaseN/A
Planned participants900
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China. Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.

This description comes directly from the study's public registry record.

Talk to the study team

Yunyun Fei  ·  +8613681125226  ·  feiyunyun2013@hotmail.com

Wen Zhang  ·  zhangwen91@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03023371